SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-06-000721
Filing Date
2006-04-10
Accepted
2006-04-10 16:23:18
Documents
4
Period of Report
2006-05-17
Effectiveness Date
2006-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A bp71820.htm DEF 14A 454461
2 GRAPHIC image001.gif GRAPHIC 3098
3 GRAPHIC image002.gif GRAPHIC 6188
4 GRAPHIC image003.jpg GRAPHIC 480
  Complete submission text file 0001206774-06-000721.txt   469780
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1220
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 06751097
SIC: 2836 Biological Products, (No Diagnostic Substances)